Filing Details
- Accession Number:
- 0001368148-21-000110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-21 17:01:38
- Reporting Period:
- 2021-09-17
- Accepted Time:
- 2021-09-21 17:01:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368148 | Athersys Inc / New | ATHX | Pharmaceutical Preparations (2834) | 204864095 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1402609 | Jr William Lehmann | 3201 Carnegie Avenue Cleveland OH 44115-2634 | Interim Ceo, President, Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-09-17 | 8,234 | $1.47 | 501,287 | No | 4 | F | Direct | |
Common Stock | Disposition | 2021-09-20 | 30,000 | $1.41 | 471,287 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares withheld from the quarterly vesting of annual restricted stock unit awards related to the tax withholding obligation.
- Shares sold pursuant to a predefined Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.44, inclusive, in accordance with a previously established Rule 10b5-1 trading plan.
- Securities beneficially owned are comprised of (1) 197,521 shares of common stock owned and (2) unvested restricted stock units aggregating 273,766 related to annual awards, which vest quarterly over a four-year period from date of grant.